Verge Genomics and Ferrer have embarked on a strategic partnership to advance the development and potential commercialization of VRG50635,...

The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...

Gilead Sciences, Inc. has finalized its acquisition of CymaBay Therapeutics, Inc. for an approximate total equity value of $4.3...

Esperion has announced a pivotal development in cardiovascular treatment, with the FDA approving broad label expansions for NEXLETOL® (bempedoic...

LIB Therapeutics, Inc. (LIB), a pioneering biopharmaceutical company, has made considerable progress with its cholesterol-lowering drug, Lerodalcibep and designed...

The “Global Digital Biomarkers Market – Outlook & Forecast 2024-2029” report showcases the rapidly expanding digital biomarkers market, which...

eGenesis, a pioneering biotechnology company, has announced a groundbreaking advancement in transplantation with the successful transplantation of a genetically...

The continent of Africa stands at a fascinating juncture in clinical trials, presenting a blend of untapped potential and...

Bristol Myers Squibb (BMY) has revealed positive outcomes from the Phase 3 CheckMate -9DW clinical trial, showcasing the effectiveness...

Tevogen Bio Holdings announced the enduring efficacy of its investigational COVID-19 treatment, TVGN 489, against the latest dominant SARS-CoV-2...